Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats

O. Nakagawa, Y. Sasaki, I. Tanaka, T. Usui, T. Sando, S. Muro, K. Mori, Hiroshi Itoh, T. Yoshimasa, S. Narumiya, K. Nakao

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

1. Prostacyclin elicits potent vasodilation and inhibition of platelet aggregation through binding to its membrane receptor. The impairment of prostacyclin receptor activity is implicated in various human cardiovascular diseases. We recently succeeded in molecular cloning of cDNA for the mouse, rat, and human prostacyclin receptors. 2. In the present study, we examined the mRNA expression of the prostacyclin receptor in various rat tissues, and further investigated its gene expression in the hypertrophied cardiac ventricles of stroke-prone spontaneously hypertensive rats (SHRSP). 3. In rat tissues, a single RNA band of approximately 3.7 kb was detected by northern blotting analysis using rat prostacyclin receptor cDNA as a probe. In adult Wistar rats, abundant mRNA expression was observed in the aorta, lung and spleen. Substantial amounts of transcript were expressed in the heart, pancreas, thymus and stomach. In contrast, no mRNA expression was detected in the brain. 4. We further examined the mRNA expression of the prostacyclin receptor in the ventricles of 21 week old SHRSP. The ventricles of SHRSP showed remarkable hypertrophy, compared with those of age-matched Wistar-Kyoto (WKY) rats. The expression of prostacyclin receptor mRNA in the hypertrophied ventricles of SHRSP was almost equivalent to that in the ventricles of WKY. 5. The present study revealed the gene expression of the prostacyclin receptor in various rat tissues, and further demonstrated the receptor mRNA expression in hypertensive cardiac hypertrophy. The present study will give a clue to investigate the clinical implication of prostacyclin and its receptor.

Original languageEnglish
JournalClinical and Experimental Pharmacology and Physiology
Volume22
Issue numberSUPPL. 1
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Epoprostenol Receptors
Inbred SHR Rats
Gene Expression
Messenger RNA
Complementary DNA
Inbred WKY Rats
Cardiomegaly
Molecular Cloning
Epoprostenol
Platelet Aggregation
Vasodilation
Northern Blotting
Thymus Gland
Hypertrophy
Heart Ventricles
Aorta
Wistar Rats
Pancreas
Stomach
Cardiovascular Diseases

Keywords

  • Cardiac hypertrophy
  • Gene expression
  • Prostacyclin
  • Prostaglandins
  • Receptor
  • Spontaneously hypertensive rat

ASJC Scopus subject areas

  • Physiology
  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Nakagawa, O., Sasaki, Y., Tanaka, I., Usui, T., Sando, T., Muro, S., ... Nakao, K. (1995). Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology, 22(SUPPL. 1).

Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats. / Nakagawa, O.; Sasaki, Y.; Tanaka, I.; Usui, T.; Sando, T.; Muro, S.; Mori, K.; Itoh, Hiroshi; Yoshimasa, T.; Narumiya, S.; Nakao, K.

In: Clinical and Experimental Pharmacology and Physiology, Vol. 22, No. SUPPL. 1, 1995.

Research output: Contribution to journalArticle

Nakagawa, O, Sasaki, Y, Tanaka, I, Usui, T, Sando, T, Muro, S, Mori, K, Itoh, H, Yoshimasa, T, Narumiya, S & Nakao, K 1995, 'Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats', Clinical and Experimental Pharmacology and Physiology, vol. 22, no. SUPPL. 1.
Nakagawa, O. ; Sasaki, Y. ; Tanaka, I. ; Usui, T. ; Sando, T. ; Muro, S. ; Mori, K. ; Itoh, Hiroshi ; Yoshimasa, T. ; Narumiya, S. ; Nakao, K. / Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats. In: Clinical and Experimental Pharmacology and Physiology. 1995 ; Vol. 22, No. SUPPL. 1.
@article{d6afad9b584a4e0e8a94efdcfd2d986a,
title = "Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats",
abstract = "1. Prostacyclin elicits potent vasodilation and inhibition of platelet aggregation through binding to its membrane receptor. The impairment of prostacyclin receptor activity is implicated in various human cardiovascular diseases. We recently succeeded in molecular cloning of cDNA for the mouse, rat, and human prostacyclin receptors. 2. In the present study, we examined the mRNA expression of the prostacyclin receptor in various rat tissues, and further investigated its gene expression in the hypertrophied cardiac ventricles of stroke-prone spontaneously hypertensive rats (SHRSP). 3. In rat tissues, a single RNA band of approximately 3.7 kb was detected by northern blotting analysis using rat prostacyclin receptor cDNA as a probe. In adult Wistar rats, abundant mRNA expression was observed in the aorta, lung and spleen. Substantial amounts of transcript were expressed in the heart, pancreas, thymus and stomach. In contrast, no mRNA expression was detected in the brain. 4. We further examined the mRNA expression of the prostacyclin receptor in the ventricles of 21 week old SHRSP. The ventricles of SHRSP showed remarkable hypertrophy, compared with those of age-matched Wistar-Kyoto (WKY) rats. The expression of prostacyclin receptor mRNA in the hypertrophied ventricles of SHRSP was almost equivalent to that in the ventricles of WKY. 5. The present study revealed the gene expression of the prostacyclin receptor in various rat tissues, and further demonstrated the receptor mRNA expression in hypertensive cardiac hypertrophy. The present study will give a clue to investigate the clinical implication of prostacyclin and its receptor.",
keywords = "Cardiac hypertrophy, Gene expression, Prostacyclin, Prostaglandins, Receptor, Spontaneously hypertensive rat",
author = "O. Nakagawa and Y. Sasaki and I. Tanaka and T. Usui and T. Sando and S. Muro and K. Mori and Hiroshi Itoh and T. Yoshimasa and S. Narumiya and K. Nakao",
year = "1995",
language = "English",
volume = "22",
journal = "Clinical and Experimental Pharmacology and Physiology",
issn = "0305-1870",
publisher = "Wiley-Blackwell",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Gene expression of prostacyclin receptor in the hypertrophied heart of spontaneously hypertensive rats

AU - Nakagawa, O.

AU - Sasaki, Y.

AU - Tanaka, I.

AU - Usui, T.

AU - Sando, T.

AU - Muro, S.

AU - Mori, K.

AU - Itoh, Hiroshi

AU - Yoshimasa, T.

AU - Narumiya, S.

AU - Nakao, K.

PY - 1995

Y1 - 1995

N2 - 1. Prostacyclin elicits potent vasodilation and inhibition of platelet aggregation through binding to its membrane receptor. The impairment of prostacyclin receptor activity is implicated in various human cardiovascular diseases. We recently succeeded in molecular cloning of cDNA for the mouse, rat, and human prostacyclin receptors. 2. In the present study, we examined the mRNA expression of the prostacyclin receptor in various rat tissues, and further investigated its gene expression in the hypertrophied cardiac ventricles of stroke-prone spontaneously hypertensive rats (SHRSP). 3. In rat tissues, a single RNA band of approximately 3.7 kb was detected by northern blotting analysis using rat prostacyclin receptor cDNA as a probe. In adult Wistar rats, abundant mRNA expression was observed in the aorta, lung and spleen. Substantial amounts of transcript were expressed in the heart, pancreas, thymus and stomach. In contrast, no mRNA expression was detected in the brain. 4. We further examined the mRNA expression of the prostacyclin receptor in the ventricles of 21 week old SHRSP. The ventricles of SHRSP showed remarkable hypertrophy, compared with those of age-matched Wistar-Kyoto (WKY) rats. The expression of prostacyclin receptor mRNA in the hypertrophied ventricles of SHRSP was almost equivalent to that in the ventricles of WKY. 5. The present study revealed the gene expression of the prostacyclin receptor in various rat tissues, and further demonstrated the receptor mRNA expression in hypertensive cardiac hypertrophy. The present study will give a clue to investigate the clinical implication of prostacyclin and its receptor.

AB - 1. Prostacyclin elicits potent vasodilation and inhibition of platelet aggregation through binding to its membrane receptor. The impairment of prostacyclin receptor activity is implicated in various human cardiovascular diseases. We recently succeeded in molecular cloning of cDNA for the mouse, rat, and human prostacyclin receptors. 2. In the present study, we examined the mRNA expression of the prostacyclin receptor in various rat tissues, and further investigated its gene expression in the hypertrophied cardiac ventricles of stroke-prone spontaneously hypertensive rats (SHRSP). 3. In rat tissues, a single RNA band of approximately 3.7 kb was detected by northern blotting analysis using rat prostacyclin receptor cDNA as a probe. In adult Wistar rats, abundant mRNA expression was observed in the aorta, lung and spleen. Substantial amounts of transcript were expressed in the heart, pancreas, thymus and stomach. In contrast, no mRNA expression was detected in the brain. 4. We further examined the mRNA expression of the prostacyclin receptor in the ventricles of 21 week old SHRSP. The ventricles of SHRSP showed remarkable hypertrophy, compared with those of age-matched Wistar-Kyoto (WKY) rats. The expression of prostacyclin receptor mRNA in the hypertrophied ventricles of SHRSP was almost equivalent to that in the ventricles of WKY. 5. The present study revealed the gene expression of the prostacyclin receptor in various rat tissues, and further demonstrated the receptor mRNA expression in hypertensive cardiac hypertrophy. The present study will give a clue to investigate the clinical implication of prostacyclin and its receptor.

KW - Cardiac hypertrophy

KW - Gene expression

KW - Prostacyclin

KW - Prostaglandins

KW - Receptor

KW - Spontaneously hypertensive rat

UR - http://www.scopus.com/inward/record.url?scp=0029611720&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029611720&partnerID=8YFLogxK

M3 - Article

C2 - 9072386

AN - SCOPUS:0029611720

VL - 22

JO - Clinical and Experimental Pharmacology and Physiology

JF - Clinical and Experimental Pharmacology and Physiology

SN - 0305-1870

IS - SUPPL. 1

ER -